PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED — Cyclosporine Importer Profile
Pharmaceutical Importer · #1 buyer for Cyclosporine · $703.0K import value · 15 shipments · TURKEY · DGFT Verified
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED is the #1 importer of Cyclosporine from India with $703.0K in import value and 15 verified shipments. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED holds a 6.2% market share in Cyclosporine imports based in TURKEY. The company sources from 1 verified supplier across 15 formulations shipped to 1 country.
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED — Cyclosporine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Cyclosporine to PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED?
Verified from 15 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CONCORD BIOTECH LIMITED | $703.0K | 15 | 100.0% |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED sources Cyclosporine from 1 verified Indian supplier based on 15 customs records. The primary supplier is CONCORD BIOTECH LIMITED accounting for 100.0% of imports.
How Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED Compare to Nearest Cyclosporine Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AVET PHARMACCEUTICALS INC., | UNITED STATES | $1.6M | 32 | $50.0K |
| 3 | AVET PHARMACCEUTICALS INC | UNITED STATES | $900.0K | 18 | $50.0K |
| 1 | PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED ★ | TURKEY | $700.0K | 14 | $50.0K |
| 4 | AVET PHARMACCEUTICALS INC. | UNITED STATES | $348.5K | 10 | $34.9K |
| 5 | M/S ARABIAN OASIS COMPANY | SAUDI ARABIA | $335.6K | 13 | $25.8K |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED ranks #1 among 319 Cyclosporine importers from India. Average shipment value of $50.0K compared to the market average of $16.2K. The closest competitors by value are AVET PHARMACCEUTICALS INC., and AVET PHARMACCEUTICALS INC.
Where Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED Import Cyclosporine To?
Destination countries from 15 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $703.0K | 15 | 100.0% |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED imports Cyclosporine to 1 country. The primary destination is TURKEY receiving 100.0% of shipments worth $703.0K.
What Cyclosporine Formulations Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| CYCLOSPORINE 25MG CONIMUNE ME 25MG CAP BATCH NOS:OHS23228/OHS23229 MANUFACTURING DT:AUG-23 EXP DT:JUL-25 TOTAL=630000 CAPSULES | $50.0K | 1 |
| CYCLOSPORINE 50MG CONIMUNE ME 50MG CAP-BATCH NO.OHS23268OHS23269 MANUFACTURING DT.OCT-23 EXP DT.SEP-25 | $50.0K | 1 |
| CYCLOSPORINE 100MG CONIMUNE ME 100MG CAP-BATCH NO.OHS23257OHS23258 MANUFACTURING DT.SEP-23 EXP DT.AUG-25 | $50.0K | 1 |
| CYCLOSPORINE 25MG CONIMUNE ME 25MG CAP-BATCH NO.OHS23261262 & OHS23228229- MANUFACTURING DT.SEP-23&AUG-23 EXP DT.AUG-25&JUL 25 | $50.0K | 1 |
| CYCLOSPORINE 100MG CONIMUNE ME 100MG CAP-BATCH NO.OHS23258OHS23259OHS23260- MANUFACTURING DT.SEP-23 EXP DT.AUG-25 | $50.0K | 1 |
| CYCLOSPORINE 25MG CONIMUNE ME 25MG CAP-BATCH NO.OHS23261 MANUFACTURING DT.SEP-23 EXP DT.AUG-25 | $50.0K | 1 |
| CYCLOSPORINE 50MG CONIMUNE ME 50MG CAP6X5SBATCH NO.OHS23273OHS23274 | $50.0K | 1 |
| CYCLOSPORINE 100MG CONIMUNE ME 100MG CAP 6X5SBATCH NO.OHS23257OHS23259OHS23260OHS23283 | $50.0K | 1 |
| CYCLOSPORINE 25MG CONIMUNE ME 25MG CAP6X5S BATCH NO. OHS23272OHS23287 | $50.0K | 1 |
| CYCLOSPORINE 25MG CONIMUNE ME - 25MG CAP 6X5S BATCH NO. OHS23261 OHS23272 | $50.0K | 1 |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED imports 15 distinct Cyclosporine formulations from India. The top formulation is CYCLOSPORINE 25MG CONIMUNE ME 25MG CAP BATCH NOS:OHS23228/OH with 1 shipments worth $50.0K.
Who Are the Top Buyers of Cyclosporine from India and How Much Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED Import?
India exported $5.2M worth of Cyclosporine through 2,531 shipments from 177 suppliers to 100 countries, serving 319 buyers globally. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED imports $703.0K of this total, accounting for 6.2% of India's Cyclosporine exports with 15 shipments from TURKEY. This is verified from 15 customs shipment records covering 15 distinct formulations.
What Is the Average Order Value for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED's Cyclosporine Imports?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED's average Cyclosporine order value is $46.9K per consignment, based on 15 shipments totaling $703.0K. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED is based in TURKEY and ranks #1 among all Cyclosporine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Cyclosporine to PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED sources Cyclosporine from 1 verified Indian supplier: CONCORD BIOTECH LIMITED ($703.0K, 100.0%). This is based on 15 customs records.
How Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED Compare to Other Cyclosporine Importers?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED ranks #1 among 319 Cyclosporine importers from India with a 6.2% market share. The top 3 importers are AVET PHARMACCEUTICALS INC., ($1.6M), AVET PHARMACCEUTICALS INC ($900.0K), PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED ($700.0K). PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED processed 15 shipments from TURKEY.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclosporine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cyclosporine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED's capped import value divided by total capped export value for Cyclosporine across all Indian exporters.
- 5.Verified Records: This page is backed by 15 individual customs records matching PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED importing Cyclosporine, covering 15 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 319+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cyclosporine Import Data for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED's Cyclosporine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED × Cyclosporine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclosporine. For current order-level data, contact TransData Nexus.